New Pathways to Navigate an Old Problem of Tuberculosis Therapy-Associated Adverse Drug Reactions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New Pathways to Navigate an Old Problem of Tuberculosis Therapy-Associated Adverse Drug Reactions

Published:2021-09 Issue:9 Volume:9 Page:3450-3451
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Trubiano Jason A.

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference14 articles.

1. Management of adverse reactions to first-line tuberculosis antibiotics;Nagarajan;Curr Opin Allergy Clin Immunol,2018

2. Reintroduction of antituberculous drugs in patients with antituberculous drug related drug reaction with eosinophilia and systemic symptoms;Oh;J Allergy Clin Immunol Pract,2021

3. Reintroducing antituberculosis therapy after Stevens-Johnson syndrome in human immunodeficiency virus-infected patients with tuberculosis: role of desensitization;Kura;Int J Dermatol,2001

4. Outcomes of reintroducing anti-tuberculosis drugs following cutaneous adverse drug reactions;Lehloenya;Int J Tuberc Lung Dis,2011

5. Delabeling delayed drug hypersensitivity: how far can you safely go?;Lehloenya;J Allergy Clin Immunol Pract,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP